Dorthe Nielsen Selected Research

NS-3728

1/2016

Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dorthe Nielsen Research Topics

Disease

1	Out-of-Hospital Cardiac Arrest 03/2022
1	Heart Arrest (Cardiac Arrest) 03/2022
1	Cognitive Dysfunction 03/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Peanut Hypersensitivity (Peanut Allergy) 11/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2016

Drug/Important Bio-Agent (IBA)

2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2016
2	Caspase 9IBA 01/2020 - 01/2016
1	trichostatin A (A 300)IBA 01/2020
1	theasinensin AIBA 01/2020
1	Taurine FDA Link 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Biological ProductsIBA 11/2017
1	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	NS-3728IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	AnionsIBA 01/2016
1	Leucine (L-Leucine)FDA Link 01/2016

Therapy/Procedure

1	Resuscitation Orders (Do Not Resuscitate Orders) 03/2022
1	Resuscitation 03/2022
1	Polypharmacy 03/2022